Ning Yu - Concepedia

Author

Ning Yu

Stanford University ORCID

Also Known As

Li, Zheng, N Y Yu, N Yu, N. Y. Yu, N. YU, N. Yu, N.Y. Yu, Nengfeng Yu, Ning Y Yu, Ning Y. Yu

Publications

1.7K

Citations

H-Index

102

Concepts

All Affiliations

Stanford University Pennsylvania State University Matrix Research (United States)Stanford Medicine Johnson & Johnson (United States)

About

Ning Yu is an author at Stanford University specializing in medicine, pharmacology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	21	1K
2	Health Sciences	3	3	227
3	Natural Sciences	3	3	169
4	Public Health	3	3	71
5	Nursing	1	1	46

Ning Yu

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
SR-2508: A 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use Jeremy Brown, Ning Yu, Dennis Brown, International Journal of Radiation OncologyBiologyPhysics Medicinal ChemistryHealth SciencesPharmacologyRadiopharmaceuticalsRadiopharmaceutical Therapy	1981	179
Radiosensitization of Hypoxic Tumor Cells by Depletion of Intracellular Glutathione Edward A. Bump, Ning Yu, J. Martin Brown Science Radiation EffectRadiation ExposurePathologyRedox BiologyTumor Biology	1982	171
Assigning the Protonation States of the Key Aspartates in β-Secretase Using QM/MM X-ray Structure Refinement Ning Yu, Seth Hayik, Bing Wang, Journal of Chemical Theory and Computation Protein ChemistryCrystal StructureBiochemistryNatural SciencesEnzyme Catalysis	2006	83
The use of drugs which deplete intracellular glutathione in hypoxic cell radiosensitization Edward A. Bump, Ning Yu, J. Martin Brown International Journal of Radiation OncologyBiologyPhysics MedicinePhototoxicityToxicologyIntracellular GlutathioneReactive Oxygen Specie	1982	82
Depletion of glutathione in vivo as a method of improving the therapeutic ratio of misonidazole and SR 2508 Ning Yu, J. Martin Brown International Journal of Radiation OncologyBiologyPhysics Therapeutic RatioBiochemistryPharmacologyClinical PharmacologyPharmacotherapy	1984	63
Refinement of protein crystal structures using energy restraints derived from linear-scaling quantum mechanics Ning Yu, Hemant P. Yennawar, Kenneth M. Merz Acta Crystallographica Section D Biological Crystallography Protein Crystal StructuresCrystal StructureProtein AssemblyBiomolecular Structure PredictionMolecular Biology	2005	56
Radiosensitization by intratumoral administration of cisplatin in a sustained-release drug delivery system Shoucheng Ning, Ning Yu, Dennis Brown, Radiotherapy and Oncology Neuro-oncologyIntratumoral AdministrationRadiation TherapyMedicineTheranostics	1999	54
Radiosensitization of hypoxic cells in vivo by SR 2508 at low radiation doses: A preliminary report J. Martin Brown, Ning Yu International Journal of Radiation OncologyBiologyPhysics Radiation OncologyRadiobiologyRadiation BiologyRadionuclide TherapyIonizing Radiation	1984	52
Pharmacokinetics, efficacy and toxicity of different pegylated liposomal doxorubicin formulations in preclinical models: is a conventional bioequivalence approach sufficient to ensure therapeutic equivalence of pegylated liposomal doxorubicin products? Rao N. V. S. Mamidi, STEVE WENG, Susan Stellar, Cancer Chemotherapy and Pharmacology Pharmaceutical SciencePreclinical Drug EvaluationBioequivalenceMedicineLiposomal Doxorubicin Products	2010	50
Bioavailability and therapeutic efficacy of HER2 scFv-targeted liposomal doxorubicin in a murine model of HER2-overexpressing breast cancer Kimberley M. Laginha, Elaine H. Moase, Ning Yu, Journal of drug targeting	2008	48

Page 1